Is tazemetostat available in an injectable form?

Tazemetostat is an oral targeted drug mainly used to treat malignant tumors such as certain types of lymphoma and sarcoma. It blocks the abnormal proliferation of tumor cells by inhibiting the activity of EZH2 enzyme. Currently, tazerestat is only available in the form of oral tablets. This administration method is convenient for patients to take at home, reduces the inconvenience of hospital visits and infusions, and improves medication compliance.

There is currently no injection form of tazetostat on the market. This is because the drug properties and mechanism of action of tazerestat determine that the oral dosage form is the most suitable method of administration. Oral administration can ensure the slow release and absorption of drugs in the body and maintain stable blood drug concentrations, thereby achieving a more ideal therapeutic effect. The injectable form of the drug is usually used for patients who need a quick onset of action or who cannot take it orally, but this is not suitable for tazerestat.

The development of injection dosage forms requires a large amount of clinical research and safety verification, which requires a large investment of time and money. Given that the oral dosage form of tazerestat can already meet the treatment needs of most patients, pharmaceutical companies have not yet embarked on the development of injectable dosage forms. In addition, injections may bring risks such as local irritation and infection, which will also increase the patient's treatment burden.
In summary, tazerestat is currently only available in oral tablet form, with no injectable dosage form available. Patients should strictly follow the doctor's instructions during use and conduct regular monitoring of efficacy and safety. If you are not suitable for oral medications or have other special needs, you should communicate with your doctor in time to seek the best individualized treatment plan.
Reference: https://www.tazverik.com/